There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

The 25-year-old joint commitment among established providers of official development assistance (ODA) to invest in efforts ...

Reductions in global health funding heighten the need for improved prioritisation of the remaining funds. Antimicrobial resistance (AMR) is an agreed priority, predicted to account for 1·91 million ...

The number of women dying during or soon after pregnancy in the UK is higher today than 10 years ago,1 with shocking reports of avoidable deaths, as articulated by The Lancet.2 ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the ...

Trusting caregivers to know their child and identify clinical changes is a fundamental principle of paediatrics. Although the ...

Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...

Water and water infrastructure are being increasingly targeted with impunity in conflicts from Gaza to Ukraine. The effects ...

Founded in 1900, the Oswaldo Cruz Foundation has made fundamental contributions to the basic understanding of infectious ...

Neurological disorders are the leading cause of disease burden, affecting more than 3 billion people worldwide, and the second leading cause of death.1 The burden of neurological disorders is ...